Trial Profile
Single-center, open-label pharmacokinetic trial of alpelisib in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Alpelisib (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- 02 Feb 2016 New trial record